Home/Specialty/Other/System, Test, Tumor Marker, For Detection Of Bladder Cancer/Alere NMP22 BladderChek Test
Alere Scarborough, Inc. D1300 Alere NMP22 BladderChek Test
Company Name
Alere Scarborough, Inc.
Catalog Number
D1300
Description
The Alere NMP22 BladderChek Test is an in vitro immunoassay intended for the qualitative detection of the nuclear mitotic apparatus protein (NuMA) in urine of persons with risk factors or symptoms of bladder cancer or with a history of bladder cancer.
Have questions or need more information? Contact Us
RevMed is an independent marketplace for reselling medical devices and equipment. We are not affiliated with or endorsed by manufacturers, and all trademarks and brand names belong to their respective owners. Product images and descriptions are for reference only, and RevMed does not provide medical advice, training, or support.
Price Not Available
Out of Stock on RevMed
Looking for ways to save?
Find Savings Automatically!
Your trusted browsing companion
How it Works
- Install the extension
- Browse the web for the medical supplies you need
- Be notified immediately when RevMed has a match
- Click the link and start saving!
Additional Details
Device Identifier
10811877010774
Is RX
Yes
Is Over the Counter
No
Requires Sterilization
No
Is Sterile
No
Is Single Use
Yes
Barcode Mapping
| Unit of Measurement | Eaches | GTIN |
|---|---|---|
| Each | 1 | 10811877010774 |